NCT03687814View on ClinicalTrials.gov

Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

NARecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

November 8, 2018

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Irritable Bowel Syndrome Characterized by Constipation
Interventions
OTHER

Low FODMAP diet/PEG 3350

Subjects will follow a low FODMAP diet and will take PEG 3350 (Miralax) at 17.7 g (single dose) daily for 4 weeks.

OTHER

sham diet/PEG 3350

Subjects will follow a sham diet and will take PEG 3350 (Miralax) at 17.7 g (single dose) daily for 4 weeks.

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER